poe-TASS-ee-um FOSS-fate 
Contraindicated in:
Use Cautiously in:
Related to hyperphosphatemia, unless otherwise indicated
CV: ARRHYTHMIAS, CARDIAC ARREST, ECG changes (absent P waves, widening of the QRS complex with biphasic curve), hypotension.
hyperkalemia: ARRHYTHMIAS, ECG changes (prolonged PR interval, ST segment depression, tall-tented T waves).
GI: diarrhea, abdominal pain, nausea, vomiting.
F and E: hyperkalemia, hyperphosphatemia, hypocalcemia, hypomagnesemia.
Local: irritation at IV site, phlebitis.
MS: hyperkalemia: muscle cramps; hypercalcemia: tremors.
Neuro: flaccid paralysis, heaviness of legs, paresthesias , confusion, listlessness, weakness.
Drug-Drug:
Drug-Food:
(Generic available)
Monobasic Potassium Phosphate
Potassium Phosphate and Sodium Phosphate
Potassium Phosphate
Monobasic Potassium Phosphate
Potassium Phosphate and Sodium Phosphate
Potassium Phosphate
Absorption: Well absorbed following oral administration. Vitamin D promotes GI absorption of phosphates.
Distribution: Phosphates enter extracellular fluids and are then actively transported to sites of action.
Metabolism/Excretion: Excreted mainly (>90%) by the kidneys.
Half-life: Unknown.
(effects on serum phosphate levels)
| ROUTE | ONSET | PEAK | DURATION |
|---|---|---|---|
| PO | unknown | unknown | unknown |
| IV | rapid (min–hr) | end of infusion | unknown |
NDC Code*